Search results
Moderna (NASDAQ:MRNA) PT Raised to $106.00
ETF DAILY NEWS· 10 hours agoModerna (NASDAQ:MRNA – Free Report) had its price target increased by Canaccord Genuity Group from $91.00 to $106.00 in a report published on Friday, Benzinga reports. Canaccord ...
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 5 days agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 21 hours agoToday, Moderna Inc (MRNA, Financial) experienced a stock price decline of 3.43%, yet it has seen a significant three-month gain of 28.21%. With a current ...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via AOL· 5 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 20 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 21 hours agoThis shift allows us to delve into its present market position and performance Present Market Standing of Moderna Trading volume stands at 914,961, with MRNA's price down ...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 5 days agoModerna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...
Why Earnings Season Could Be Great for Moderna (MRNA)
Zacks· 6 days agoThis suggests that analysts have very recently bumped up their estimates for MRNA, giving the stock a Zacks Earnings ESP of +0.99% heading into earnings ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoSales are expected to accelerate in a big way in the third quarter, with a projected $1.61 billion,...
Director AFEYAN NOUBAR sale 15,000 shares of Moderna Inc [MRNA] – Knox Daily
Knox Daily· 3 days agoGenuity has initiated its “Hold” rating for MRNA. Earlier on November 03, 2023, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA ...